Seattle Lawyer Cindy Runger Joins IDRI Board of Directors

October 19th, 2017|Press Releases|

FOR IMMEDIATE RELEASE: Seattle, WA | Oct. 19, 2017: Cindy Runger, a senior finance and legal executive who most recently served in a leadership role with U.S. Trust, has joined the Board of Directors of IDRI (Infectious Disease Research [...]

Promising New Leprosy Vaccine Moves into Human Trials

October 12th, 2017|Press Releases|

FOR IMMEDIATE RELEASE: SEATTLE, WA, & GREENVILLE, SC | Oct. 12, 2017: Today marks a significant step forward in the prevention and treatment of leprosy as the Infectious Disease Research Institute (IDRI) and American Leprosy Missions announce the start of a [...]

IDRI Collaborates on Novel Vaccine for Ebola & Other Hemorrhagic Fever Viruses

October 5th, 2017|Press Releases|

FOR IMMEDIATE RELEASE: Seattle | Oct. 5, 2017: IDRI (Infectious Disease Research Institute) is part of a new consortium formed to prepare and test a vaccine formulation designed to protect against the Ebola, Sudan, Marburg, and Lassa fever viruses. If successful, [...]

Quratis Teams with IDRI on TB Vaccine

August 30th, 2017|Press Releases|

SEATTLE & SEOUL | Aug. 30, 2017 FOR IMMEDIATE RELEASE: Quratis Inc. announced Wednesday that the company had applied for the phase 2 of clinical trials in Korea for an adult tuberculosis vaccine developed by scientists at the Infectious Disease Research Institute [...]

IDRI to Continue Development of Inhalable TB Drug Candidate

August 24th, 2017|Press Releases|

  IDRI's Steve Reed, left, signs TB agreement with Hisun officials as part of a ceremony to commemorate the 30th anniversary of the friendship relationship between the state of Indiana and Zheijiang Province. SEATTLE | Aug. 24, 2017 FOR [...]

IDRI Teams with WSOS for Summer Internships for UW Students

July 17th, 2017|Press Releases|

FOR IMMEDIATE RELEASE: Seattle | July 17, 2017: With a focus on training the next generation of global health scientists, the Infectious Disease Research Institute (IDRI) is partnering with the Washington State Opportunity Scholarship (WSOS) to provide four internships [...]

IDRI Expands Leadership with Addition of Chief Medical Officer; New Chief Scientific Officer

June 1st, 2017|Press Releases|

FOR IMMEDIATE RELEASE: Seattle | June 1, 2017 : The Infectious Disease Research Institute (IDRI) announced today that Corey Casper, MD, MPH, has joined IDRI’s executive team as its Chief Medical Officer. Casper comes to IDRI from the Fred [...]

IDRI & NanoPass Sign Agreement to Develop an Intradermal rvRNA-Based Zika Virus Vaccine

February 14th, 2017|Press Releases|

FOR IMMEDIATE RELEASE: Seattle, WA, & Nes Ziona, Israel| Feb. 14, 2017: Zika remains a major public health threat, and its devastating neurological effects on newborns and infants are still being unraveled. More than ever, a vaccine is needed [...]

IDRI Expands Board with Former Starbucks Executive

February 9th, 2017|Press Releases|

SEATTLE| Feb. 9, 2017 FOR IMMEDIATE RELEASE: Seattle | Feb. 9, 2017 : Richard Lautch, a senior finance leader who most recently served as an executive with Starbucks Coffee Co., has joined the Board of Directors of IDRI (Infectious Disease Research Institute) and [...]

IDRI Contributes to First Point-of-Care Chagas Disease Diagnostic for U.S.

January 12th, 2017|Press Releases|

SEATTLE | Jan. 12, 2017 FOR IMMEDIATE RELEASE: Seattle | Jan. 12, 2017 : With Chagas disease becoming more prevalent in the United States, a diagnostic to quickly and easily detect infection is needed. Today, IDRI (Infectious Disease Research Institute) announces that [...]

Load More